In a report released today, Joon Lee from Truist Financial maintained a Buy rating on Corcept Therapeutics (CORT – Research Report), with a price target of $76.00. The company’s shares closed ...

Canaccord Genuity maintained its Buy rating and $78.00 price target for NASDAQ:CORT, Corcept Therapeutics (NASDAQ:CORT). The firm highlighted the company's solid performance as the third quarter ...

Corcept (CORT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). Corcept, Amneal, Bioventus, Foghorn and Akebia have ...

Truist has recently raised Corcept Therapeutics Incorporated (CORT) stock to Buy rating, as announced on November 6, 2023, according to Finviz. Earlier, on April 11, 2023, SVB Securities had initiated ...

Truist has recently raised Corcept Therapeutics Incorporated (CORT) stock to Buy rating, as announced on November 6, 2023, according to Finviz. Earlier, on April 11, 2023, SVB Securities had initiated ...

After hours: October 18 at 7:15 PM EDT Loading Chart for CORT ...

Canaccord Genuity maintained its Buy rating and $78.00 price target for NASDAQ:CORT, Corcept Therapeutics (NASDAQ:CORT). The firm highlighted the company's solid performance as the third quarter comes ...

We run through the main garden furniture types and accessories, where to buy them from and how to care for them so you don’t need to buy replacements year after year. Plus, we've got tips on how to ...